Trials / Completed
CompletedNCT00612326
Feasibility Evaluation of Magnetic Resonance Imaging and Positron Emission Tomography for Bladder Cancer Diagnosis and Staging
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 26 (actual)
- Sponsor
- Memorial Sloan Kettering Cancer Center · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to to find out if the MRI and PET scans can truly stage patients with bladder cancer. Both scans use newer ways to find out if your disease has grown beyond the bladder. The radioactive tracer used for the PET scan is called C-11 Acetate. We want to see if PET scan will be able to take a picture of the inside of your body that is better than other scans such as the CT scan and MRI. Therefore, the findings of the PET scan will be compared with other imaging studies as well as the surgical findings.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | MRI and PET scanning procedures | a CT scan, MRI, and C-11 Acetate PET scan. All these scans will be done as an outpatient. After you finish these scans, your doctor will schedule you for surgery to remove your bladder and lymph nodes. |
Timeline
- Start date
- 2004-06-01
- Primary completion
- 2008-03-01
- Completion
- 2008-03-01
- First posted
- 2008-02-11
- Last updated
- 2015-12-18
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00612326. Inclusion in this directory is not an endorsement.